Latest Zydus Group News & Updates

See the latest news and media coverage for Zydus. We track all announcements, press releases, and industry mentions in real time, all in one place.

Zydus Group (Zydus)

Global pharmaceutical company

zyduslife.com

Headquarters: Ahmedabad, India
Company type: Public company
Number of employees: 21,000+
Industry: Pharmaceuticals

Last updated October 13

Latest news about Zydus Group (Zydus)

In short: Zydus secured USFDA approvals and pipeline milestones while Q1 profit fell despite revenue growth.

Company announcements

October 13 Zydus

Zydus receives USFDA review for FYB206 biosimilar

The BLA acceptance marks the first publicly announced Keytruda biosimilar filing. Formycon earned a milestone payment from Zydus under their exclusive agreement.

August 31 Zydus

Zydus announces positive Phase II(b) results for Saroglitazar Mg in MASH

The trial met its primary endpoint. Results will be presented at upcoming scientific meetings and submitted for publication.

August 12 Zydus

Zydus reports financial results for quarter ended June 30, 2026

The unaudited consolidated net profit after tax was INR 9,398 million, with total income from operations of INR 80,170 million for the quarter.

August 11 Zydus

Zydus reports 22% YoY revenue growth in Q1 FY27

Net profit declined 35.9% YoY, EBITDA margin fell to 24.1%, while acquisitions and a Sri Lanka JV were announced.

Media coverage

October 12 Medical Dialogues

Zydus, Formycon Hit Major USFDA Milestone for First USD 31 Billion Keytruda Biosimilar

Indian pharmaceutical major Zydus Lifesciences Limited and German biosimilar developer Formycon AG have achieved a significant regulatory milestone, jointly announcing that the US...

August 18 Business Standard

Delhi HC restrains Zydus from launching Dabrafenib till patent expiry

Zydus undertakes not to commercially manufacture or launch Dabrafenib until Novartis' Indian patent expires in May 2029; statutory Bolar rights remain protected...

August 12 The Financial Express

India pharma rebounds with Sun, Zydus leading an overall 12.1% growth in July

India's pharmaceutical market is showing signs of good health in 2026, after a relatively weak calendar year 2024 and 2025. In July 2026, sales jumped...

August 11 CNBC TV18

Zydus Lifesciences Q1 Results: Stock jumps over 6%; India biz leads growth

Zydus Lifesciences shares gained 5% on Tuesday, August 11 after the company reported its first quarter earnings. The stock had initially come off the day's...

Never miss news about Zydus

Track Zydus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Zydus competitors & trending companies

Browse news for competitors to Zydus and other trending companies.